QGEN vs. DLB
QGEN (Qiagen N.V.) and DLB (Dolby Laboratories, Inc.) are both stocks. QGEN operates in Diagnostics & Research (Healthcare), while DLB operates in Information Technology Services (Technology). Over the past 10 years, QGEN returned 6.62%/yr vs 1.52%/yr for DLB. At a 0.32 correlation, their price movements are largely independent.
Performance
QGEN vs. DLB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QGEN achieves a -7.02% return, which is significantly higher than DLB's -21.54% return. Over the past 10 years, QGEN has outperformed DLB with an annualized return of 6.62%, while DLB has yielded a comparatively lower 1.52% annualized return.
QGEN
- 1D
- -1.14%
- 1M
- 11.93%
- 6M
- -13.26%
- YTD
- -7.02%
- 1Y
- -13.12%
- 3Y*
- -2.41%
- 5Y*
- -3.63%
- 10Y*
- 6.62%
DLB
- 1D
- -0.64%
- 1M
- -5.18%
- 6M
- -21.70%
- YTD
- -21.54%
- 1Y
- -32.30%
- 3Y*
- -16.07%
- 5Y*
- -11.74%
- 10Y*
- 1.52%
QGEN vs. DLB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
QGEN Qiagen N.V. | -7.02% | 1.51% | 2.44% | -12.91% | -10.27% | 5.17% | 56.36% | -1.89% | 11.38% | 10.49% |
DLB Dolby Laboratories, Inc. | -21.54% | -16.27% | -7.95% | 23.82% | -24.90% | -0.99% | 42.99% | 12.63% | 0.78% | 38.73% |
Correlation
The correlation between QGEN and DLB is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.39 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Feb 17, 2005 | 0.32 |
The correlation between QGEN and DLB shifts across timeframes, from 0.28 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
QGEN:
$8.56B
DLB:
$4.76B
QGEN:
$1.90
DLB:
$2.53
QGEN:
21.85
DLB:
19.68
QGEN:
0.28
DLB:
29.04
QGEN:
4.19
DLB:
3.51
QGEN:
2.60
DLB:
1.82
QGEN:
$2.10B
DLB:
$1.36B
QGEN:
$1.29B
DLB:
$1.19B
QGEN:
$714.95M
DLB:
$347.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QGEN vs. DLB — Risk / Return Rank
QGEN
DLB
QGEN vs. DLB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Qiagen N.V. (QGEN) and Dolby Laboratories, Inc. (DLB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QGEN | DLB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.87 | ||
| Sortino ratioReturn per unit of downside risk | +1.32 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 0.77 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.34 | -0.96 | +0.62 |
| Martin ratioReturn relative to average drawdown | -0.68 | -1.93 | +1.24 |
Loading charts...
Drawdowns
QGEN vs. DLB - Drawdown Comparison
The maximum QGEN drawdown since its inception was -92.14%, which is greater than DLB's maximum drawdown of -62.19%. Use the drawdown chart below to compare losses from any high point for QGEN and DLB.
Loading charts...
Drawdown Indicators
| QGEN | DLB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.14% | -62.19% | -29.95% |
Max Drawdown (1Y)Largest decline over 1 year | -41.38% | -34.38% | -7.00% |
Max Drawdown (3Y)Largest decline over 3 years | -41.38% | -42.30% | +0.92% |
Max Drawdown (5Y)Largest decline over 5 years | -42.43% | -47.81% | +5.38% |
Max Drawdown (10Y)Largest decline over 10 years | -42.43% | -48.40% | +5.97% |
Current DrawdownCurrent decline from peak | -26.75% | -47.89% | +21.14% |
Average DrawdownAverage peak-to-trough decline | -47.33% | -22.45% | -24.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.33% | 17.02% | +3.31% |
Volatility
QGEN vs. DLB - Volatility Comparison
Qiagen N.V. (QGEN) has a higher volatility of 12.68% compared to Dolby Laboratories, Inc. (DLB) at 7.26%. This indicates that QGEN's price experiences larger fluctuations and is considered to be riskier than DLB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QGEN | DLB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.68% | 7.26% | +5.42% |
Volatility (6M)Calculated over the trailing 6-month period | 29.28% | 21.24% | +8.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.66% | 25.60% | +8.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.99% | 25.14% | +0.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.21% | 26.62% | +0.59% |
Dividends
QGEN vs. DLB - Dividend Comparison
QGEN's dividend yield for the trailing twelve months is around 6.36%, more than DLB's 2.83% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | 2.83% | 2.10% | 1.57% | 1.29% | 1.45% | 0.96% | 0.91% | 1.15% | 1.08% | 0.94% | 1.11% | 1.25% |
QGEN Qiagen N.V. | 6.36% | 0.56% | 2.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.36% | 0.00% | 0.00% |
Financials
QGEN vs. DLB - Financials Comparison
This section allows you to compare key financial metrics between Qiagen N.V. and Dolby Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
QGEN vs. DLB - Profitability Comparison
QGEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Qiagen N.V. reported a gross profit of 307.87M and revenue of 492.32M. Therefore, the gross margin over that period was 62.5%.
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Dolby Laboratories, Inc. reported a gross profit of 350.90M and revenue of 395.63M. Therefore, the gross margin over that period was 88.7%.
QGEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Qiagen N.V. reported an operating income of 117.22M and revenue of 492.32M, resulting in an operating margin of 23.8%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Dolby Laboratories, Inc. reported an operating income of 112.95M and revenue of 395.63M, resulting in an operating margin of 28.6%.
QGEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Qiagen N.V. reported a net income of 68.04M and revenue of 492.32M, resulting in a net margin of 13.8%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Dolby Laboratories, Inc. reported a net income of 94.92M and revenue of 395.63M, resulting in a net margin of 24.0%.
Frequently Asked Questions
QGEN and DLB have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QGEN has higher volatility (12.68%) compared to DLB (7.26%). In terms of maximum drawdown, QGEN dropped -92.14% vs DLB's -62.19%.
QGEN currently has the higher Sharpe Ratio (-0.41 vs -1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QGEN and DLB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer